Select region
Submit
All products

Advanta V12 balloon expandable covered stent

Right from the start - Still going strong

Questions? Contact us.
Balloon expandable covered stent.
Conformable, deliverable, flexible. Designed to track through tortuous arteries and flex to accommodate the iliac and renal anatomy.
Advanta V12 Balloon Expandable Covered Stent

Advanta V12 balloon expandable covered stent

Advanta V12 is the first to market balloon expandable, fully encapsulated stent that has served physicians with more than 850,000 units sold. Known for its precision and predictability – the versatile Advanta V12 covered stent has been meeting the needs of surgeons and patients for 20 years, and is the only durable solution backed by decades of real-world evidence.[1][2]

Indications:

The Advanta V12 balloon expandable covered stent is indicated for restoring and improving the patency of the iliac and renal arteries. Renal approval includes 5mm, 6mm and 7mm diameter Advanta V12 sizes. In Canada, the Advanta V12 covered stent indication excludes renal arteries.

The Advanta V12 balloon expandable covered stent is not available in the U.S.

 

 

The predictability and precision you need for covered stent placement. [1]

Versatility to adapt to different treatment needs, with flexibility to conform to the anatomy.[1] [7] [8] [9] [10]

Predictable & Precise

  • Designed for secure delivery & placement: Average stent securement force is 2-4 times higher than peak insertion forces [1]

  • 6 French compatible with most common renal sizes* [1]

  • Radiopaque markers enhance visibility during deployment and assist with accurate stent placement [1]

  • Designed for pushability and trackability through tortuous anatomy with conformance to iliac and renal arteries [1]

  • Predictable recoil and foreshortening promotes precise deployment [1]

 
* Please see the Advanta V12 order information found in the documents tab for detailed compatibility
Group of stents

Versatile & Flexible

  • Low profile, reliable stent retention force, and secure trackability facilitate the stent implantation [1]

  • Full encapsulation with ePTFE minimizes neointimal hyperplasia formation and helps mitigate the risks related to vessel perforation [1][7][10]

  • Smooth inner lumen offers ease of navigation during re-intervention [1]

  • Able to post-dilate and flare stent: conforming to the anatomy and customizing each patient's treatment [1][9]

  • 316L stainless steel struts provide additional radial force, designed to support the patency of the stent [1]

  • Dog-bone inflation design is intended to reduce the chances of embolization[8]

Advanta large diameter

Large Diameter

  • 12mm large diameter stents with 9 Fr compatibility offers increased treatment options and direct access to aorto-iliac anatomy [1]

  • Expands from 12 to 16 mm [1]

Optimized patient outcomes today, tomorrow and into the future. [3][4][5][6]

COBEST - 5 year results: Advanta V12 vs. Bare Metal Stent [3]

  • Significantly higher patency in complex TASC C&D lesions compared to bare metal stents at 5 years (p=0.003).
  • Proven two-fold lower reintervention compared to bare metal stents at 5 years post-procedure.
Click here to read more

Systematic review of covered balloon-expandable stents for treating aortoiliac occlusive disease [2]

  • The Advanta V12/iCast balloon-expandable covered stent has long-term, real-world follow-up, including a reported 5-year primary patency rate of 74.7%.
  • The Advanta V12/iCast was the most common device studied in the literature from 2000-2019 (10/15 publications; 66.7%).
  • The Advanta V12/iCast studies treated patients with more severe disease (a greater number of TASC C&D lesions) and more severe symptoms (more Rutherford classification 4 & 5) compared to patients enrolled in clinical trials studying other covered balloon-expandable stents.
  • Freedom from TLR: Results were comparable for all covered balloon-expandable stents at 1 year. The Advanta V12/iCast has long-term target lesion revascularization data.
Click here to read more
Journal of Vascular Surgery

iCARUS: Single-Arm IDE study with 3-year follow-up [5]

 

 

  • Real-world patient population with multiple lesions and bilateral disease​.
  • Study showed sustained clinical benefit with freedom from Target Lesion Revascularization (TLR) up to 3 years. 
Click here to read more

Pre and post images from occlusive disease treatment with Advanta V12

Bilateral illiac artery occlusion

Bilateral Iliac artery occlusion - pre restoration

Pre treatment

Bilateral Iliac artery occlusion - post restoration

Post treatment

Restoration of the lumen diameter with 10x38 mm Advanta V12 covered stent in RIA; 10x59 mm and 10x38 mm Advanta V12 covered stents overlapped in LIA.

Bilateral common iliac artery occlusion

Bilateral Common Iliac artery occlusion - pre restoration

Pre treatment

Bilateral Common Iliac artery occlusion - post restoration

Post treatment

Restoration of the lumen diameter with 8x59 mm Advanta V12 covered stents in RIA and LIA. 

Renal artery stenosis

Renal artery stenosis - pre restoration

Pre treatment

Renal artery stenosis - post restoration

Post treatment

Restoration of the lumen diameter with Advanta V12 covered stents in LRA.

RIA - Right Iliac Artery, LIA - Left Iliac Artery, LRA - Left Renal Artery, RRA - Right Renal Artery

  1. 1. Data on file.

  2. 2. Mwipatayi, B.P., et al., A systematic review of covered balloon-expandable stents for treating aorto-iliac occlusive disease. Journal of Vascular Surgery, 2020.

  3. 3. Mwipatayi, B.P., et al., Durability of the balloon-expandable covered versus bare-metal stents in the Covered versus Balloon Expandable Stent Trial (COBEST) for the treatment of aortoiliac occlusive disease. Journal of Vascular Surgery, 2016

  4. 4. Harris W., et al., Covered stents convey improved performance over bare metal stents for artherosclerotic renal artery stenosis. J Vasc Surg, 2013

  5. 5. Laird et al., iCAST Balloon-Expandable Covered Stent for Iliac Artery Lesions: 3-Year Results from the iCARUS Multicenter Study. Journal of Vascular and Interventional Radiology, 2019

  6. 6. Sabri S, et al., Outcomes of Covered Kissing Stent Placement Compared with Bare Metal Stent Placement in the Treatment of Atherosclerotic Occlusive Disease at the Aortic Bifurcation. Journal of Vascular and Interventional Radiology, 2010

  7. 7. Feldman D. et al. "SCAI guidelines on device selection in Aorto-Iliac arterial interventions. Catheter Cardiovasc Interv, 2020

  8. 8. Grimme et al.; Polytetrafluoroethylene Covered Stent Placement for Focal Occlusive Disease of the Infrarenal Aorta; Eur J Vasc Endovasc Surg, 2014.

  9. 9. van der Riet et al., Three-Dimensional Geometric Analysis of Balloon-Expandable Covered Stents Improves Classification of Complications after Fenestrated Endovascular Aneurysm Repair. J of Clinical Medicine, 202

  10. 10. Rogers C, et al., Non-GLP study of biologic responses to uncoated and PTFE coated steel stents in rabbit iliac arteries. MIT iCast IH Study, 1997

You are now leaving Getinge.com. You might access content  not managed by Getinge team, in that case Getinge can not be hold responsible of the content. 

I understand! Stay in Getinge.com

Dear user, you have clicked a link and will now see International fallback content.
Getinge ANZ does not review or control this content. It is possible that some of the products on Getinge International are not approved in your country. For more specific Australian information please contact us 

OK!

Dear user, You now see International fallback content. Getinge ANZ does not review or control this content. It is possible that some of the products on Getinge international are not approved in your country. For more specific  information relevant for your region please contact us.